Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease – an overview

References

• Adluri RS, Thirunavukkarasu M, Zhan L, Akita Y, Samuel SM, Otani H, Ho YS, Maulik G, Maulik N. 2011. Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice. J Mol Cell Cardiol 50:239–247.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Roussel AM, Zouari N, Mahjoub S, Matheau JM, Kerkeni A. 2001. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr 20:212–218.
   PubMed Web of Science ®Google Scholar
• Aragno M, Mastrocola R, Catalano MG, Brignardello E, Danni O, Boccuzzi G. 2004. Oxidative stress impairs skeletal muscle repair in diabetic rats. Diabetes 53:1082–1088.
   PubMed Web of Science ®Google Scholar
• Aragno M, Parola S, Brignardello E, Mauro A, Tamagno E, Manti R, Danni O, Boccuzzi G. 2000. Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes 49:1924–1931.
   PubMed Web of Science ®Google Scholar
• Bartels GL, Remme WJ, Pillay M, Schönfeld DH, Cox PH, Kruijssen HA, Knufman NM. 1992. Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans. J Cardiovasc Pharmacol 20:157–164.
   Google Scholar
• Battiprolu PK, Gillette TG, Wang ZV, Lavandero S, Hill JA. 2010. Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets. Drug Discov Today Dis Mech 7:e135–e143.
   Google Scholar
• Boudina S, Abel ED. 2007. Diabetic cardiomyopathy revisited. Circulation 115:3213–3223.
   PubMed Web of Science ®Google Scholar
• Brignardello E, Gallo M, Aragno M, Manti R, Tamagno E, Danni O, Boccuzzi G. 2000. Dehydroepiandrosterone prevents lipid peroxidation and cell growth inhibition induced by high glucose concentration in cultured rat mesangial cells. J Endocrinol 166:401–406.
   Google Scholar
• Brownlee M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820.
   PubMed Web of Science ®Google Scholar
• Brownlee M. 2005. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625.
   PubMed Web of Science ®Google Scholar
• Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. 1993. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 90:6434–6438.
   PubMed Web of Science ®Google Scholar
• Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, Shah AM. 2006. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 8:691–728.
   PubMed Web of Science ®Google Scholar
• Ceriello A. 2003. New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care 26:1589–1596.
   PubMed Web of Science ®Google Scholar
• Coughlin SS, Pearle DL, Baughman KL, Wasserman A, Tefft MC. 1994. Diabetes mellitus and risk of idiopathic dilated cardiomyopathy. The Washington, DC Dilated Cardiomyopathy Study. Ann Epidemiol 4:67–74.
   Google Scholar
• de Rekeneire N. 2006. Diabetes and cognitive function in older adults. J Nutr Health Aging 10:285–286.
   Google Scholar
• Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. 2002. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067–2072.
   PubMed Web of Science ®Google Scholar
• Farahmand F, Lou H, Singal PK. (2003) Oxidative stress in cardiovascular complications of diabetes. In: Pierce G.N., Naganop M., Zahradka P., Dhalla N.S. (Eds). Atherosclerosis, hypertension, and diabetes. Boston: Kluwer Academic Publisher.
   Google Scholar
• Fuliang HU, Hepburn HR, Xuan H, Chen M, Daya S, Radloff SE. 2005. Effects of propolis on blood glucose, blood lipid and free radicals in rats with diabetes mellitus. Pharmacol Res 51:147–152.
   PubMed Web of Science ®Google Scholar
• Gao L, Mann GE. 2009. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 82:9–20.
   PubMed Web of Science ®Google Scholar
• Gao X, Belmadani S, Picchi A, Xu X, Potter BJ, Tewari-Singh N, Capobianco S, Chilian WM, Zhang C. 2007. Tumor necrosis factor-α induces endothelial dysfunction in Lepr(db) mice. Circulation 115:245–254.
   PubMed Web of Science ®Google Scholar
• Green K, Brand MD, Murphy MP. 2004. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 53 Suppl 1:S110–S118.
   PubMedGoogle Scholar
• Hallenbeck JM. 2002. The many faces of tumor necrosis factor in stroke. Nat Med 8:1363–1368.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. (1999) Free Radicals in Biology and Medicine. Oxford: Oxford University Press.
   Google Scholar
• Hansson GK. 2005. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695.
   PubMed Web of Science ®Google Scholar
• Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T. 2001. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88:E14–E22.
   PubMed Web of Science ®Google Scholar
• Ichikawa T, Oeda T, Ohmori H, Schill WB. 1999. Reactive oxygen species influence the acrosome reaction but not acrosin activity in human spermatozoa. Int J Androl 22:37–42.
   PubMedGoogle Scholar
• Indulekha K, Anjana RM, Surendar J, Mohan V. 2011. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem 44:281–287.
   PubMed Web of Science ®Google Scholar
• Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H. 2000. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C–dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49:1939–1945.
   PubMed Web of Science ®Google Scholar
• Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL. 1996. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 272:728–731.
   PubMed Web of Science ®Google Scholar
• Ishii H, Koya D, King GL. 1998. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med 76:21–31.
   PubMed Web of Science ®Google Scholar
• Iwasaki Y, Asai M, Yoshida M, Nigawara T, Kambayashi M, Nakashima N. 2004. Dehydroepiandrosterone-sulfate inhibits nuclear factor-kappaB-dependent transcription in hepatocytes, possibly through antioxidant effect. J Clin Endocrinol Metab 89:3449–3454.
   PubMedGoogle Scholar
• Johansen JS, Harris AK, Rychly DJ, Ergul A. 2005. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 4:5.
   PubMed Web of Science ®Google Scholar
• Kakkar R, Kalra J, Mantha SV, Prasad K. 1995. Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol Cell Biochem 151:113–119.
   PubMed Web of Science ®Google Scholar
• Kaul N, Siveski-Iliskovic N, Hill M, Khaper N, Seneviratne C, Singal PK. 1996. Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy. Mol Cell Biochem 160-161:283–288.
   PubMedGoogle Scholar
• Kaul N, Siveski-Iliskovic N, Thomas TP, Hill M, Khaper N, Singal PK. 1995. Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy. Nutrition 11:551–554.
   PubMed Web of Science ®Google Scholar
• King H, Aubert RE, Herman WH. 1998. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431.
   PubMed Web of Science ®Google Scholar
• Lipinski B. 2011. Hydroxyl radical and its scavengers in health and disease. Oxid Med Cell Longev 2011:809696.
   PubMed Web of Science ®Google Scholar
• Luther JM, Brown NJ. 2011. The renin-angiotensin-aldosterone system and glucose homeostasis. Trends Pharmacol Sci 32:734–739.
   PubMed Web of Science ®Google Scholar
• Maack C, Kartes T, Kilter H, Schäfers HJ, Nickenig G, Böhm M, Laufs U. 2003. Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment. Circulation 108:1567–1574.
   PubMed Web of Science ®Google Scholar
• Matsui H, Okumura K, Mukawa H, Hibino M, Toki Y, Ito T. 1997. Increased oxysterol contents in diabetic rat hearts: their involvement in diabetic cardiomyopathy. Can J Cardiol 13:373–379.
   PubMed Web of Science ®Google Scholar
• Mauldin JP, Nagelin MH, Wojcik AJ, Srinivasan S, Skaflen MD, Ayers CR, McNamara CA, Hedrick CC. 2008. Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus. Circulation 117:2785–2792.
   Google Scholar
• Menke T, Niklowitz P, Wiesel T, Andler W. 2008. Antioxidant level and redox status of coenzyme Q10 in the plasma and blood cells of children with diabetes mellitus type 1. Pediatr Diabetes 9:540–545.
   PubMed Web of Science ®Google Scholar
• Miwa S, Watada H, Omura C, Takayanagi N, Nishiyama K, Tanaka Y, Onuma T, Kawamori R. 2005. Anti-oxidative effect of fluvastatin in hyperlipidemic type 2 diabetic patients. Endocr J 52:259–264.
   PubMed Web of Science ®Google Scholar
• Natali A, Vichi S, Landi P, Severi S, L’Abbate A, Ferrannini E. 2000. Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia 43:632–641.
   PubMedGoogle Scholar
• Newsholme P, Haber EP, Hirabara SM, Rebelato EL, Procopio J, Morgan D, Oliveira-Emilio HC, Carpinelli AR, Curi R. 2007. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol (Lond) 583:9–24.
   Google Scholar
• Nishikawa T, Edelstein D, Brownlee M. 2000. The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl 77:S26–S30.
   PubMed Web of Science ®Google Scholar
• Ohkuwa T, Sato Y, Naoi M. 1995. Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci 56:1789–1798.
   PubMed Web of Science ®Google Scholar
• Park Y, Capobianco S, Gao X, Falck JR, Dellsperger KC, Zhang C. 2008. Role of EDHF in type 2 diabetes-induced endothelial dysfunction. Am J Physiol Heart Circ Physiol 295:H1982–H1988.
   PubMed Web of Science ®Google Scholar
• Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM, Zhang C. 2006. Tumor necrosis factor-α induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 99:69–77.
   PubMed Web of Science ®Google Scholar
• Qian S, Huo D, Wang S, Qian Q. 2011. Inhibition of glucose-induced vascular endothelial growth factor expression by Salvia miltiorrhiza hydrophilic extract in human microvascular endothelial cells: evidence for mitochondrial oxidative stress. J Ethnopharmacol 137:985–991.
   Google Scholar
• Rahman I, Gilmour PS, Jimenez LA, MacNee W. 2002. Oxidative stress and TNF-α induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol Cell Biochem 234-235:239–248.
   PubMed Web of Science ®Google Scholar
• Ramasamy R, Yan SF, Schmidt AM. 2009. RAGE: therapeutic target and biomarker of the inflammatory response–the evidence mounts. J Leukoc Biol 86:505–512.
   PubMed Web of Science ®Google Scholar
• Rauscher FM, Sanders RA, Watkins JB 3rd. 2001. Effects of coenzyme Q10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 15:41–46.
   PubMed Web of Science ®Google Scholar
• Roebuck KA. 1999. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (Review). Int J Mol Med 4:223–230.
   PubMed Web of Science ®Google Scholar
• Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. 1972. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:595–602.
   PubMed Web of Science ®Google Scholar
• Samuel SM, Thirunavukkarasu M, Penumathsa SV, Koneru S, Zhan L, Maulik G, Sudhakaran PR, Maulik N. 2010. Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats. Circulation 121:1244–1255.
   Google Scholar
• Singal PK, Petkau A, Gerrard JM, Hrushovetz S, Foerster J. 1988. Free radicals in health and disease. Mol Cell Biochem 84:121–122.
   PubMed Web of Science ®Google Scholar
• Son SM. 2007. Role of vascular reactive oxygen species in development of vascular abnormalities in diabetes. Diabetes Res Clin Pract 77 Suppl 1:S65–S70.
   Google Scholar
• Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. 1998. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97:2222–2229.
   PubMed Web of Science ®Google Scholar
• Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS. 2002. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 25:1055–1059.
   PubMed Web of Science ®Google Scholar
• Taniguchi N, Kaneto H, Asahi M, Takahashi M, Wenyi C, Higashiyama S, Fujii J, Suzuki K, Kayanoki Y. 1996. Involvement of glycation and oxidative stress in diabetic macroangiopathy. Diabetes 45 Suppl 3:S81–S83.
   Google Scholar
• Touyz RM. 2004. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44:248–252.
   PubMed Web of Science ®Google Scholar
• Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A, Dandona P. 2003. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52:2882–2887.
   PubMed Web of Science ®Google Scholar
• Vinik A, Flemmer M. 2002. Diabetes and macrovascular disease. J Diabetes Complicat 16:235–245.
   Google Scholar
• Wellen KE, Hotamisligil GS. 2005. Inflammation, stress, and diabetes. J Clin Invest 115:1111–1119.
   PubMed Web of Science ®Google Scholar
• Westermann D, Van Linthout S, Dhayat S, Dhayat N, Schmidt A, Noutsias M, Song XY, Spillmann F, Riad A, Schultheiss HP, Tschöpe C. 2007. Tumor necrosis factor-α antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 102:500–507.
   PubMed Web of Science ®Google Scholar
• Wu JH, Ward NC, Indrawan AP, Almeida CA, Hodgson JM, Proudfoot JM, Puddey IB, Croft KD. 2007. Effects of α-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes. Clin Chem 53:511–519.
   PubMed Web of Science ®Google Scholar
• Wu QD, Wang JH, Fennessy F, Redmond HP, Bouchier-Hayes D. 1999. Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am J Physiol 277:C1229–C1238.
   PubMed Web of Science ®Google Scholar
• Yamagishi SI, Edelstein D, Du XL, Brownlee M. 2001. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes 50:1491–1494.
   PubMed Web of Science ®Google Scholar
• Yiginer O, Ozcelik F, Inanc T, Aparci M, Ozmen N, Cingozbay BY, Kardesoglu E, Suleymanoglu S, Sener G, Cebeci BS. 2008. Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome. Clin Res Cardiol 97:334–340.
   PubMedGoogle Scholar
• Yorek MA, Coppey LJ, Gellett JS, Davidson EP, Bing X, Lund DD, Dillon JS. 2002. Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. Am J Physiol Endocrinol Metab 283:E1067–E1075.
   PubMed Web of Science ®Google Scholar